Faslodex 250 Mg Injection 5 ml In 1vial
Faslodex 250 Mg Injection 5 ml In 1vial

Faslodex 250 Mg Injection 5 ml In 1vial

MOQ : 10 Packs

Faslodex 250 Mg Injection 5 ml In 1vial Specification

  • Dosage Form
  • Injection
  • Salt Composition
  • Fulvestrant 250 mg
  • Indication
  • Hormone receptor positive metastatic breast cancer in postmenopausal women
  • Feature
  • Ready to use prefilled syringe, single-dose vial
  • Ingredients
  • Fulvestrant
  • Application
  • Antineoplastic (cancer treatment)
  • Physical Color/Texture
  • Clear, colorless to yellow, viscous liquid
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store at 2C to 8C (Refrigerated). Do not freeze.
  • Shelf Life
  • 24 months from manufacturing date
  • Molecular Formula
  • C32H47F5O3
  • Packaging
  • 5 ml in 1 vial (prefilled syringe)
  • Prescription
  • Prescription only medication
  • Patient Group
  • Adults (postmenopausal women)
  • Country of Export
  • Canada, EU, UK, USA, Australia
  • Route of Administration
  • Intramuscular injection
  • CAS Number
  • 129453-61-8
  • Batch/Manufacturing Number
  • As per package
  • Storage Condition
  • Keep away from sunlight and out of reach of children
  • ATC Code
  • L02BA03
  • Contraindications
  • Pregnancy, hypersensitivity to fulvestrant
  • Administration Frequency
  • Typically once a month, as directed by healthcare provider
 
 

Faslodex 250 Mg Injection 5 ml In 1vial About



Faslodex 250 Mg Injection 5 ml In 1vial distinguishes itself as an elite antineoplastic therapy, crafted for superior performance in hormone receptor-positive metastatic breast cancer. Exclusively prescribed for postmenopausal women, this exceptional treatment utilizes a ready-to-use prefilled syringe for convenient intramuscular administration. Manufactured in India for global export, including Canada, EU, UK, USA, and Australia, Faslodex represents the pinnacle of reliability. Explore enhanced patient comfort and consistent results, with each single-dose vial guaranteeing purity and safety. Promotion of effective cancer management has never been more accessible or refined.

Specific Usage and Material Feature: Faslodex 250 Mg Injection Highlights

Faslodex 250 Mg Injection is specifically indicated for treating hormone receptor-positive metastatic breast cancer in postmenopausal women. Its advanced formulation, including 250 mg of Fulvestrant in a prefilled, single-dose syringe, makes it ideal for hospital and specialty clinic settings. The clear, viscous liquid ensures accurate dosing, while its odorless character enhances patient comfort. This elite product is ready to use, reducing preparation time and the risk of contamination, ensuring reliable and consistent therapy every time.


Main Domestic Market and Efficient Order Handling

Faslodex 250 Mg Injection is available for seamless order processing across domestic and international markets, including Canada, EU, UK, USA, and Australia. A transparent sample policy and flexible payment terms ensure user convenience. From the moment your order is processed to safe transportation and timely handover, every step is handled with professionalism. Orders are expeditiously managed to preserve product integrity, thanks to strict cold-chain requirements and well-coordinated logistics that uphold the elite standards of this superior medication.


FAQ's of Faslodex 250 Mg Injection 5 ml In 1vial:


Q: How is Faslodex 250 Mg Injection administered?

A: Faslodex 250 Mg Injection is given as an intramuscular injection, typically once a month, by a healthcare professional as directed by your physician.

Q: What are the main benefits of using Faslodex 250 Mg Injection?

A: The main benefit is its effectiveness in treating hormone receptor-positive metastatic breast cancer in postmenopausal women, offering consistent, easy-to-administer therapy in a prefilled syringe.

Q: When should Faslodex 250 Mg Injection not be used?

A: Faslodex should not be used during pregnancy or in patients who have hypersensitivity to fulvestrant as it may cause adverse reactions.

Q: Where should Faslodex 250 Mg Injection be stored?

A: Store the injection in a refrigerated environment at 2C to 8C. Do not freeze and keep it away from sunlight and out of reach of children.

Q: What is the process for ordering and receiving Faslodex 250 Mg Injection?

A: Orders are processed promptly with coordinated logistics for safe transportation, ensuring the medicine is handed over safely while maintaining strict temperature controls throughout the supply chain.

Q: How does the prefilled syringe feature enhance Faslodex usage?

A: The ready-to-use prefilled syringe minimizes preparation time, reduces risk of dosage errors, and ensures sterile, single-dose administration every time, enhancing reliability and safety.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Injection Category

Raniprime-50 Ranitidine 50 mg Injection

Raniprime-50 Ranitidine 50 mg Injection

Minimum Order Quantity : 10 Pieces

Ingredients : Other , Ranitidine Hydrochloride, Water for injections, Buffering agents

Feature : Other, Fast acting, reliable acid suppression, parenteral use

Indication : Gastroesophageal reflux disease (GERD), Peptic ulcer, ZollingerEllison syndrome

Shelf Life : Typically 2 years (refer to packaging for expiry)

Salt Composition : Ranitidine 50 mg

Human Normal immunoglobulin For Intravenous 100ml

Human Normal immunoglobulin For Intravenous 100ml

Minimum Order Quantity : 10 Pieces

Ingredients : Other , Human immunoglobulin G (IgG), Stabilizers

Feature : Other, Sterile, Pyrogenfree, Readytouse for intravenous administration

Indication : Primary Immunodeficiency, Secondary Immunodeficiency, Immunomodulation

Shelf Life : 2 3 years from manufacturing date

Salt Composition : Human Normal Immunoglobulin

Actemra Tocilizumab 400mg Injection

Actemra Tocilizumab 400mg Injection

Minimum Order Quantity : 10 Pieces

Ingredients : Other , Tocilizumab

Feature : Other, Prescription Only, Monoclonal Antibody, Biological Product

Indication : Treatment of Rheumatoid Arthritis, Cytokine Release Syndrome (CRS), and other inflammatory conditions

Shelf Life : 24 months (from date of manufacture)

Salt Composition : Tocilizumab 400mg

Bonmax PTH 750mcg Solution Injection

Bonmax PTH 750mcg Solution Injection

Minimum Order Quantity : 10 Pieces

Ingredients : Other , Teriparatide and excipients

Feature : Other, Prefilled autoinjector pen

Indication : Osteoporosis, bone loss

Shelf Life : As mentioned on pack, generally 24 months from manufacturing

Salt Composition : Teriparatide 750 mcg



Back to top